1st Quarter - Report
LINCOLN POLICY GROUP for PFIZER
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Outreach regarding vaccine co-pay language in CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act) Outreach on biosimilar shared savings.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN ELLING | — |
| ROBERT HOLIFIELD New | Staff Director, Senate Agriculture Committee; Staff Director, Senate Finance Subcmte on Int'l Trade; Deputy Chief of Staff, CFTC; Director of External Affairs, CFTC |
| HANNAH LAMBIOTTE SMITH New | Legislative Correspondent, Sen. Blanche Lincoln; Legislative Assistant; Sen. Blanche Lincoln; Staff Director, Senate Finance Subcmte Trade |
| BLANCHE LINCOLN | — |
| COLIN ROSKEY | — |
| THOMAS A SCULLY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.